Marietta Investment Partners LLC Exelixis, Inc. Transaction History
Marietta Investment Partners LLC
- $396 Million
- Q1 2025
A detailed history of Marietta Investment Partners LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Marietta Investment Partners LLC holds 71,694 shares of EXEL stock, worth $2.86 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
71,694
Previous 54,294
32.05%
Holding current value
$2.86 Million
Previous $1.81 Million
46.43%
% of portfolio
0.67%
Previous 0.42%
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
603Shares Held
255MCall Options Held
1.38MPut Options Held
962K-
Black Rock Inc. New York, NY33.5MShares$1.33 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.14 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$934 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$591 Million0.88% of portfolio
-
State Street Corp Boston, MA11.4MShares$455 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.8B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...